CNC vs HUM
Centene Corporation and Humana, both Healthcare
Humana is the larger company at $43B against $30B. Over the past year CNC returned +160% against +54% for HUM. Ryufin's sector-relative Smart Score puts CNC ahead, 8/10 against 6/10.
| Figure | CNC | HUM |
|---|---|---|
| Last close | $65.47 | $391 |
| Market cap | $30B | $43B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | n/a | 41.7 |
| Dividend yield | n/a | 0.9% |
| 1-year return | +160% | +54% |
| 5-year return | -4.6% | -3.7% |
| Ryufin Smart Scoresector-relative, 1–10 | 8/10 | 6/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Centene Corporation
Revenue of $54B in Q2 2026, net income $1.1B. Its largest reported line is Medicaid, 54% of the disclosed total.
Humana
Revenue of $40B in Q1 2026, net income $1.2B. Its largest reported line is Center Well, 85% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.